| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |